Evaluating Donor-Derived Versus iPSC-Derived NK Therapies to Understand Advantages & Drawbacks of Each
Time: 1:05 pm
day: Pre-Conference Workshop Day
Details:
Dive into the source of NK cell therapies in this dynamic workshop, where we debate donor-derived versus iPSC-derived NK cells. Uncover the distinct advantages and challenges of each approach, from clinical effectiveness, editing efficiency to scalability. Gain the insights needed to make strategic decisions in sourcing NK cells.
- Comparing and contrasting different sources of NK cells to understand which is most appropriate for a certain application
- Evaluate challenges such as inconsistent gene editing in donor-derived cells, concerns in lack of thymic education in iPSC-derived cells, donor-to-donor variation, and drawbacks in homogenous iPSC populations
- Uncover the manufacturing challenges associated with producing donor-derived versus iPSC-derived NK therapies, including cost, complexity, and scalability
- Learn how to optimize the selection of NK cell sources based on specific patient needs, disease types, and treatment goals
